Comment
doi: 10.1111/apt.16127.
Letter: TIPSS improves muscle mass indices in patients with cirrhosis and severe portal hypertension
Affiliations
- PMID: 33333611
- DOI: 10.1111/apt.16127
Item in Clipboard
Comment
Letter: TIPSS improves muscle mass indices in patients with cirrhosis and severe portal hypertension
Aliment Pharmacol Ther.
2021 Jan.
No abstract available
Comment in
-
Letter: TIPSS improves muscle mass indices in patients with cirrhosis and severe portal hypertension - authors' reply.Aliment Pharmacol Ther. 2021 Jan;53(1):199-200. doi: 10.1111/apt.16154. Aliment Pharmacol Ther. 2021. PMID: 33333598 No abstract available.
Comment on
-
Consequences of TIPSS placement on the body composition of patients with cirrhosis and severe portal hypertension: a large retrospective CT-based surveillance.Aliment Pharmacol Ther. 2020 Nov;52(9):1516-1526. doi: 10.1111/apt.16080. Epub 2020 Sep 15. Aliment Pharmacol Ther. 2020. PMID: 32931618
Similar articles
-
Letter: TIPSS improves muscle mass indices in patients with cirrhosis and severe portal hypertension - authors' reply.Aliment Pharmacol Ther. 2021 Jan;53(1):199-200. doi: 10.1111/apt.16154. Aliment Pharmacol Ther. 2021. PMID: 33333598 No abstract available.
-
Letter: TIPSS is a promising therapy for sarcopenia in cirrhosis.Aliment Pharmacol Ther. 2021 Jan;53(1):209. doi: 10.1111/apt.16128. Aliment Pharmacol Ther. 2021. PMID: 33333606 No abstract available.
-
TIPSS and reversal of sarcopenia, and TIPSS is a promising therapy for sarcopenia in cirrhosis-Authors' reply.Aliment Pharmacol Ther. 2021 Jan;53(1):211-212. doi: 10.1111/apt.16152. Aliment Pharmacol Ther. 2021. PMID: 33333608 No abstract available.
-
Changes in body composition after transjugular intrahepatic portosystemic stent in cirrhosis: a critical review of literature.Liver Int. 2011 Oct;31(9):1250-8. doi: 10.1111/j.1478-3231.2011.02498.x. Epub 2011 Mar 8. Liver Int. 2011. PMID: 21745273 Review.
-
[Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in liver cirrhosis: intended population and timing].Zhonghua Gan Zang Bing Za Zhi. 2017 Jun 20;25(6):402-407. doi: 10.3760/cma.j.issn.1007-3418.2017.06.002. Zhonghua Gan Zang Bing Za Zhi. 2017. PMID: 28763854 Review. Chinese.
References
REFERENCES
-
- Artru F, Miquet X, Azahaf M, et al. Consequences of TIPSS placement on the body composition of patients with cirrhosis and severe portal hypertension: a large retrospective CT-based surveillance. Aliment Pharmacol Ther. 2020;52:1516-1526.
-
- Durand F, Buyse S, Francoz C, et al. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. J Hepatol. 2014;60:1151-1157.
-
- Golse N, Bucur PO, Ciacio O, et al. A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation. Liver Transpl. 2017;23:143-154.
-
- Nardelli S, Lattanzi B, Torrisi S, et al. Sarcopenia is risk factor for development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement. Clin Gastroenterol Hepatol. 2017;15:934-936.
-
- Dunne PDJ, Sinha R, Stanley AJ, et al. Randomised clinical trial: Standard of care versus early-transjugular intrahepatic porto-systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding. Aliment Pharmacol Ther. 2020;52:98-106.